Provided by Tiger Trade Technology Pte. Ltd.

Vertex, Inc.

12.71
-0.0600-0.47%
Volume:240.13K
Turnover:3.07M
Market Cap:2.06B
PE:576.72
High:12.97
Open:12.77
Low:12.66
Close:12.77
52wk High:26.54
52wk Low:10.21
Shares:162.00M
Float Shares:70.89M
Volume Ratio:0.49
T/O Rate:0.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0220
EPS(LYR):0.0444
ROE:1.46%
ROA:0.65%
PB:8.54
PE(LYR):286.29

Loading ...

Vertex Pharmaceuticals is Maintained at Underperform by Baird

Dow Jones
·
Jul 07

Baird Adjusts Price Target on Vertex Pharmaceuticals to $350 From $330

MT Newswires Live
·
Jul 07

Why Is Crinetics Stock (CRNX) Surging Nearly 100% in Pre-Market Today, 7/7/26? Analysts React

TIPRANKS
·
Jul 07

Vertex’s $10 Billion Crinetics Acquisition Adds Endocrinology Growth Pillars, Supporting Long-Term Buy Thesis

TIPRANKS
·
Jul 07

Vertex Minerals Launches $0.10 Share Purchase Plan for Existing Investors

TIPRANKS
·
Jul 07

Crinetics downgraded to Neutral from Overweight at Cantor Fitzgerald

TIPRANKS
·
Jul 07

Vertex to Acquire Crinetics in $10 Billion Merger

TIPRANKS
·
Jul 07

M&A News: Vertex Stock (VRTX) Slips After Announcing $10B Crinetics Acquisition

TIPRANKS
·
Jul 07

Vertex to acquire Crinetics for $85 per share in cash

TIPRANKS
·
Jul 07

Vertex Signs Letter of Intent for Cystic Fibrosis Therapy in Canada

MT Newswires Live
·
Jul 06

Vertex enters LOI with pan-Canadian Pharmaceutical Alliance for ALYFTREK

TIPRANKS
·
Jul 06

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 03

Clear Secure Stock And 2 Travel Tech Picks For Airport Queue Disruption

Simply Wall St.
·
Jul 03

Vertex Pharmaceuticals Says FDA Approves Expanded Use of Casgevy in Younger Children With Blood Disorders

MT Newswires Live
·
Jul 02

Vertex announces FDA approval for expanded use of Casgevy

TIPRANKS
·
Jul 02

Vertex Minerals to Issue 12 Million Long-Dated Options on ASX

TIPRANKS
·
Jul 01

Vertex Minerals Expands Share Capital Through Option Exercises

TIPRANKS
·
Jun 30

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jun 30

Vertex Inc : TD Cowen Initiates Coverage with Buy Rating; Price Target $14

THOMSON REUTERS
·
Jun 29

TD Cowen Initiates Vertex at Buy With $14 Price Target

MT Newswires Live
·
Jun 29